WELLESLEY, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), announced that members of its executive team are scheduled to participate in the upcoming investor conferences detailed below.

Guggenheim Securities Healthcare Innovation Conference

Format: Fireside chat and one-on-one investor meetings

Date: November 11-12, 2024

Stifel 2024 Healthcare Conference

Get the latest news
delivered to your inbox
Sign up for The Manila Times newsletters
By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service and Privacy Policy.

Format: Fireside chat and one-on-one investor meetings

Date: November 18-19, 2024

36th Annual Piper Sandler Healthcare Conference

Format: Fireside chat and one-on-one investor meetings

Date: December 3-5, 2024

7th Annual Evercore ISI HealthCONx Conference

Format: Fireside chat and one-on-one investor meetings

Date: December 3-5, 2024

The presentations will be webcast live and available for replay under "News & Events” in the Investors section of the Company's website at climbbio.com.

About Climb Bio, Inc.

Climb Bio, Inc., is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Company's lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has potential to treat a broad range of B-cell mediated diseases. For more information, please visit climbbio.com.

Investors

Chris Brinzey

ICR Healthcare

[email protected]

339-970-2843

Media

Jon Yu

ICR Healthcare

[email protected]

475-395-5375